Life360 (LIF) director sells shares after exercising stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Life360, Inc. director Chris Hulls reported an option exercise and related share sale. He exercised stock options for 27,000 shares of common stock at an exercise price of $8.19 per share, then sold 15,133 shares of common stock at a weighted average price of $39.43 per share.
Following these transactions, Hulls directly holds 334,319 shares of common stock and also reports indirect holdings through 2023 irrevocable trusts. The filing notes that the sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 16, 2025, and that 108,371 restricted stock units are included in his reported holdings.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 15,133 shares ($596,694)
Net Sell
6 txns
Insider
Hulls Chris
Role
Director
Sold
15,133 shs ($597K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 27,000 | $0.00 | -- |
| Exercise | Common Stock | 27,000 | $8.19 | $221K |
| Sale | Common Stock | 15,133 | $39.43 | $597K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 206,801 shares (Direct);
Common Stock — 349,452 shares (Direct);
Common Stock — 195,312 shares (Indirect, Held by the Robin Hulls 2023 Irrevocable Trust)
Footnotes (1)
- The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Includes 108,371 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $39.23 to $39.71, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. Represents shares of the Issuer's common stock underlying 585,938 CDIs. The stock option is fully vested and exercisable.
FAQ
What insider transactions did Life360 (LIF) director Chris Hulls report on this Form 4?
Chris Hulls reported exercising stock options and selling shares of Life360 common stock. He exercised options for 27,000 shares at $8.19 per share and sold 15,133 shares at a weighted average price of $39.43 per share under a Rule 10b5-1 plan.
What Life360 (LIF) stock options did Chris Hulls exercise in this Form 4?
Hulls exercised a fully vested stock option covering 27,000 shares of Life360 common stock. The option had an exercise price of $8.19 per share and an expiration date of May 20, 2028, and was reported as fully vested and exercisable in the filing.
Does the Form 4 mention Life360 (LIF) restricted stock units held by Chris Hulls?
Yes. The disclosure notes that Hulls’ reported holdings include 108,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Life360 common stock upon vesting, adding to his overall equity-based compensation exposure.